Research & development increased 144.2%
Research & development changed +144.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development changed +144.2% from the comparable as-filed period.
Current ratio changed +47.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed +433 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Working capital changed +195.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed -89.8% from the comparable as-filed period.
Stock-based compensation changed +23.8% from the comparable as-filed period.
Current assets changed +131.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Research & development changed -90.1% from the comparable as-filed period.
Total assets changed +134.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital / assets changed +2244 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Working capital changed +208.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed +409.7% from the comparable as-filed period.
Capital expenditure changed -21.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.